Financial Performance - Q2 FY2027 vs Q2 FY2026

Quantitative Results:

  • Revenue from Operations: Increased by 30.73% to ₹274.23 crore (from ₹209.76 crore in Q2 FY2026)
  • Sales Volume: Increased by 10.08% to 11,028.46 MT (from 10,018 MT in Q2 FY2026)
  • EBITDA: Increased by 29.80% to ₹51.27 crore (from ₹39.50 crore in Q2 FY2026)
  • Net Profit: Increased by 36.06% to ₹21.09 crore (from ₹15.48 crore in Q2 FY2026)
  • EBITDA per kg: ₹46.50, representing a 30% increase year-on-year

Financial Performance - H1 FY2027 vs H1 FY2026

Quantitative Results:

  • Revenue from Operations: Increased by 27.62% to ₹574.67 crore (from ₹450.32 crore in H1 FY2026)
  • Sales Volume: Increased by 8.04% to 23,116.98 MT (from 21,395 MT in H1 FY2026)
  • EBITDA: Increased by 23.97% to ₹107.70 crore (from ₹86.81 crore in H1 FY2026)
  • Net Profit: Increased by 23.18% to ₹46.67 crore (from ₹37.89 crore in H1 FY2026)

Segment-wise Performance (Q2 FY2027 vs Q2 FY2026)

Volume Growth by Segment:

  • Pharma Packaging: 26.30% year-on-year growth
  • Food & FMCG Packaging (including Q-Pack): 23.70% year-on-year growth
  • Paints Packaging: 8.61% year-on-year growth
  • Lubricants Packaging: 12.32% year-on-year decline

Operational Highlights and Management Commentary

Challenges Faced:

  • Uncertain geopolitical situation
  • Sharp increases in raw material prices
  • Constraints in material availability due to geopolitical disruptions

Success Factors:

  • Successful pass-through of raw material cost increases to customers through pre-agreed pricing arrangements
  • Improved operational efficiencies
  • Better product mix with higher margin segments contributing more

Business Development:

  • New Customers Acquired: Kannan Fiber Industries, Mittal Polymers Private Limited, Avakaaya Foods (food industry), Pharmaforce, Life wise Pharmaceuticals (pharma industry)
  • Panipat Unit-14: Contributing to Food & FMCG segment sales in North India

Future Prospects and Expansion Plans

New Product Launches:

  • IODEX containers: Commercial production starting from Q3 FY2027
  • New packs under development: For 3 additional multinational companies (expected revenue from Q4 FY2027)
  • Eye dropper packs: Moulds expected by Q4 FY2027, commercial production from Q1 FY2028
  • Innovative dual packs: Market adoption achieved, expected launch in Q4 FY2027

New Market Entries:

  • Company actively working on entering Trays, Dosing Pens, and Semi-conductors packaging for sustained growth

Capacity Optimization:

  • Integration of printing facilities under one roof in Sultanpur, Telangana
  • Expected benefits: streamlined workflows, reduced operational costs, improved turnaround times, better resource utilization

Pharma Packaging Expansion:

  • Continued investments in advanced manufacturing capabilities
  • Specialized packaging solutions development
  • Capacity enhancement initiatives
  • Expected to emerge as important growth driver

Company Background

Mold-Tek Packaging Limited is a leader in manufacturing injection moulded rigid plastic packaging containers, established in 1986 and publicly listed in 1993. The company operates 12 manufacturing units and 2 stock points pan-India with current installed injection molding capacity of over 66,000 TPA. The company pioneered In-Mold Labeling (IML) concept in India and is the only packaging company in India that designs and manufactures in-house robots for IML decoration.